[
  {
    "ts": null,
    "headline": "CVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy?",
    "summary": "CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.",
    "url": "https://finnhub.io/api/news?id=f75df543eeb7133b64c5f6fb7b945d370b0217d2af78eb539747d948792d4f25",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750186800,
      "headline": "CVS Surges on Regulatory Relief, Medicare Advantage Push: Time to Buy?",
      "id": 135341198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS surges 53.7% YTD as regulatory relief, strong execution and Medicare Advantage momentum fuel investor confidence.",
      "url": "https://finnhub.io/api/news?id=f75df543eeb7133b64c5f6fb7b945d370b0217d2af78eb539747d948792d4f25"
    }
  },
  {
    "ts": null,
    "headline": "VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma",
    "summary": "Veeva Systems launches China Campaign Manager to boost pharma engagement with localized, compliant CRM-driven solutions.",
    "url": "https://finnhub.io/api/news?id=7a89f1966a3625adc08eb173f44375bb9a41ac1289d51b7e1e6b7d642c76631f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750174740,
      "headline": "VEEV Stock May Gain on the Launch of China Campaign Manager for Pharma",
      "id": 135335826,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Veeva Systems launches China Campaign Manager to boost pharma engagement with localized, compliant CRM-driven solutions.",
      "url": "https://finnhub.io/api/news?id=7a89f1966a3625adc08eb173f44375bb9a41ac1289d51b7e1e6b7d642c76631f"
    }
  },
  {
    "ts": null,
    "headline": "Wells Fargo Remains Bullish on CVS Health (CVS) With an $84 PT",
    "summary": "CVS Health Corporation (NYSE:CVS) is one of the 13 Most Undervalued Retail Stocks to Buy Right Now. On June 5, Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health Corporation (NYSE:CVS) and set a price target of $84.00. The company’s fiscal Q1 2025 results support the Buy rating, with total revenues increasing […]",
    "url": "https://finnhub.io/api/news?id=cf41ab4303e2b2e904cd4f335ffde7b4df54b23973c0f3da641d4115df458c8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750173755,
      "headline": "Wells Fargo Remains Bullish on CVS Health (CVS) With an $84 PT",
      "id": 135335828,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health Corporation (NYSE:CVS) is one of the 13 Most Undervalued Retail Stocks to Buy Right Now. On June 5, Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health Corporation (NYSE:CVS) and set a price target of $84.00. The company’s fiscal Q1 2025 results support the Buy rating, with total revenues increasing […]",
      "url": "https://finnhub.io/api/news?id=cf41ab4303e2b2e904cd4f335ffde7b4df54b23973c0f3da641d4115df458c8a"
    }
  },
  {
    "ts": null,
    "headline": "5 Low Price-to-Book Value Stocks That You Can Buy in June",
    "summary": "The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.",
    "url": "https://finnhub.io/api/news?id=2990f9aabb057e329a6de8fce0bbf01e1cce7e3ac534574c5cab666d306b3d73",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750165320,
      "headline": "5 Low Price-to-Book Value Stocks That You Can Buy in June",
      "id": 135335830,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "The P/B ratio helps to identify low-priced stocks with high growth prospects. USNA, CVS, PFE, STNE and PSFE are some such stocks.",
      "url": "https://finnhub.io/api/news?id=2990f9aabb057e329a6de8fce0bbf01e1cce7e3ac534574c5cab666d306b3d73"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Industry Outlook Highlights CVS Health, BrightSpring Health Services and GeneDx",
    "summary": "CVS, BrightSpring, and GeneDx are tapping into AI, staffing trends, and precision medicine to drive future healthcare gains.",
    "url": "https://finnhub.io/api/news?id=886265483fa7a3d86fb9015b650653d48270f24571deb27dd46848e6aaf7365e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750165140,
      "headline": "Zacks Industry Outlook Highlights CVS Health, BrightSpring Health Services and GeneDx",
      "id": 135327802,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS, BrightSpring, and GeneDx are tapping into AI, staffing trends, and precision medicine to drive future healthcare gains.",
      "url": "https://finnhub.io/api/news?id=886265483fa7a3d86fb9015b650653d48270f24571deb27dd46848e6aaf7365e"
    }
  },
  {
    "ts": null,
    "headline": "Walgreens’ lost decade: How M&A mania and retail neglect shrunk a $100 billion giant to a $10 billion private equity gamble",
    "summary": "As Walgreens exits Wall Street after 98 years, its new owners face a daunting turnaround. Will a renewed focus on its pharmacies and more financial discipline be enough?",
    "url": "https://finnhub.io/api/news?id=5fa1807b565c03428d70f60a9d99f0b2547afa9debc4823a5c47df73ecc80b75",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750158000,
      "headline": "Walgreens’ lost decade: How M&A mania and retail neglect shrunk a $100 billion giant to a $10 billion private equity gamble",
      "id": 135335835,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "As Walgreens exits Wall Street after 98 years, its new owners face a daunting turnaround. Will a renewed focus on its pharmacies and more financial discipline be enough?",
      "url": "https://finnhub.io/api/news?id=5fa1807b565c03428d70f60a9d99f0b2547afa9debc4823a5c47df73ecc80b75"
    }
  }
]